Status:
UNKNOWN
Rate Control in Atrial Fibrillation
Lead Sponsor:
Creighton University
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
This study will evaluate the efficacy of metoprolol tartrate compared to carvedilol on heart rate control in patients with atrial fibrillation and a rapid ventricular rate.
Eligibility Criteria
Inclusion
- Permanent atrial fibrillation
- Baseline ventricular rate (prior to treatment) \> 110 bpm
Exclusion
- History of accessory tract re-entry tachycardia
- Ejection fraction \< 35% or history of NYHA Class III/IV stage C/D heart failure
- Acute coronary syndrome, percutaneous coronary intervention, or cardiac surgery in the past 2 months
- Child-Pugh class B or C hepatic dysfunction
- Uncontrolled hypertension
- Thyroid disease
- Intolerance to beta-blockers
- History of lung disease resulting in hospitalization in the past year
Key Trial Info
Start Date :
December 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2017
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02251509
Start Date
December 1 2016
End Date
September 1 2017
Last Update
June 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Creighton University
Omaha, Nebraska, United States, 68178